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Although mature myocytes rely on mitochondria as
the primary source of energy, the role of mitochon-
dria in the developing heart is not well known. Here,
we find that closure of themitochondrial permeability
transition pore (mPTP) drives maturation of mito-
chondrial structure and function and myocyte differ-
entiation. Cardiomyocytes at embryonic day (E) 9.5,
when compared to E13.5, displayed fragmented
mitochondria with few cristae, a less-polarized mito-
chondrial membrane potential, higher reactive
oxygen species (ROS) levels, and an open mPTP.
Pharmacologic and genetic closing of the mPTP
yielded maturation of mitochondrial structure and
function, lowered ROS, and increased myocyte
differentiation (measured by counting Z bands).
Furthermore, myocyte differentiation was inhibited
and enhanced with oxidant and antioxidant treat-
ment, respectively, suggesting that redox-signaling
pathways lie downstream of mitochondria to regu-
late cardiac myocyte differentiation.
INTRODUCTION
The heart is the first functional organ to form in the embryo,
beginning at about embryonic day (E) 8 in the mouse, becoming
a looped tube by E9.5, and resulting in a fully septated heart at
around E13.5. Embryos can survive with abnormally formed
hearts; however, they cannot survive if the heart does not func-
tion well enough to provide effective circulation (Conway et al.,
2003). Despite the recent advances in cardiac developmental
biology, in many cases the exact causes of embryonic cardiac
failure are not well understood. A few studies demonstratedDevelopmenthat mitochondria are important to the development of the heart,
as dysfunction of the mitochondrial electron transport chain
(ETC) can cause heart malformation and embryonic death
between E8.5 and E10.5, suggesting that mitochondrial function
is essential to cardiac function and survival of the embryo (Ingra-
ham et al., 2009; Larsson et al., 1998).
Mitochondria in the adult heart are well characterized and
occupy over 30% of the cell volume. It is thought that complex
mitochondrial networks exist within the adult heart myocyte
for the transmission of substrates and ATP to the inner parts
of the cell by diffusion through connected, filamentous mito-
chondria (Skulachev, 2001). Generally, mitochondrial mor-
phology in mature cells correlates with mitochondrial function,
as changes in mitochondrial fusion or fission require the pinch-
ing off or fusing of both the outer and inner mitochondrial
membranes (IMMs), thereby affecting cristae morphology and
the diffusion of ADP (Mannella, 2006). In contrast, much less
is known about mitochondria and bioenergetics in the devel-
oping heart (reviewed in Porter et al., 2011). Mitochondria in
preimplantation embryos undergo cyclic changes in their IMM
structure. During the blastocyst stage, the IMM is less complex
compared to earlier or later stages (Dumollard et al., 2009). A
few studies demonstrate that, as the heart establishes pla-
cental-embryonic circulation, the cardiac mitochondria mature,
and similar changes are seen during cardiac stem cell differen-
tiation (Chung et al., 2007; Krishnan et al., 2008; Shepard et al.,
1998). However, the transition from immature mitochondrial
structure and function in early myocytes to a mature mitochon-
drial network in the adult myocyte has not been investigated in
detail.
In this study, we examined the relatively unexplored role of
mitochondrial biology in the embryonic heart. We found that
the mitochondrial permeability transition pore (mPTP) is open
in the early heart and that closure of this mPTP led to dramatic
maturation of mitochondrial structure and function, which accel-
erated myocyte differentiation. We modulated mPTP opening
using pharmacological agents that affect the adenine nucleosidetal Cell 21, 469–478, September 13, 2011 ª2011 Elsevier Inc. 469
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mPTP Control of Cardiomyocyte Differentiationtranslocase (ANT), a potential component of the mPTP, and
Cyclophilin D (CyP-D), a mitochondrial matrix peptidyl-prolyl
cis-trans isomerase that is known to regulate mPTP opening
(Baines and Molkentin, 2009; Brookes et al., 2004; Crompton,
1999; Gunter and Sheu, 2009; Halestrap, 2009; Lemasters
et al., 2009), or genetic deletion of the ppif gene that encodes
CyP-D (Baines et al., 2005; Elrod et al., 2010). Although mPTP
opening is generally associated with apoptosis, our findings indi-
cate that mPTP opening in early embryonic heart is nonpatho-
logic. In addition, mPTP closure quickly decreased intracellular
reactive oxygen species (ROS) levels, and treatment with exog-
enous oxidants and antioxidants also regulated myocyte differ-
entiation, regardless of the state of the mPTP. Our findings
suggest a critical role of the embryonic mPTP as a mediator of
mitochondrial maturation and cardiac differentiation via redox
signaling and suggest that the mPTP and oxidative state may
be targets to modulate cardiac development and function in
the embryo and fetus and to enhance cardiac myocyte differen-
tiation for cardiac regeneration.
RESULTS
Mitochondrial Morphology, Ultrastructure, and Mass
Change during Embryonic Cardiac Development
We examined mitochondrial morphology using epifluorescence
and confocal microscopy in cultured ventricular myocytes from
C57BL/6N mice loaded with MitoTracker Green (MTG). At
E9.5, mitochondria were fragmented, round and dilated, while
at E13.5, mitochondria were more elongated and branched,
forming thin, filamentous, interconnected networks (Figures
1A, 1C, 2A, 2B, and 4A). Cellular organization also changed;
whereas the E9.5mitochondria were frequently clustered around
the nucleus with little association with the immature contractile
apparatus, the E13.5 mitochondria were arranged more in a
linear pattern spanning the length of the cell and between the
developing contractile filaments (Figures 1A–1C and 4A). Statis-
tical analysis revealed that mitochondrial length, network
complexity, and area increased during the embryonic period
(Figure 1D, and see Figures S1A–S1D available online).
Electron microscopy (EM) of whole-embryo hearts was per-
formed to examine details of mitochondrial ultrastructure. At
each developmental stage, mitochondria were classified based
on the arrangement of the cristae and the matrix. The mitochon-
dria were divided into four classes: class 1 is ‘‘very immature’’
and has rare or no cristae and an expanded matrix; class 2 is
‘‘immature’’ and has sparse, tubular cristae with a few tubular
cristae connections to the periphery and a slightly expanded
matrix; class 3 is ‘‘almost mature’’ and has many and better-
defined cristae and many tubular cristae connections to the
periphery, but a mostly compacted matrix and occasional matrix
translucence/‘‘voids’’; and class 4 is ‘‘mature’’ and has abun-
dant, organized/laminar cristae with multiple tubular connec-
tions to the periphery and a compacted matrix with no voids
(Figure S1E). As demonstrated in Figure 1E, mitochondria from
E9.5 hearts tended to have immature cristae compared to those
from older embryos, and quantification confirmed a progressive
and statistically significant increase in mitochondrial class
distribution as the hearts developed, suggesting a ‘‘maturation’’
of mitochondrial ultrastructure (Figure 1F).470 Developmental Cell 21, 469–478, September 13, 2011 ª2011 ElsIn addition, western blot analysis revealed that the expression
of the mitochondrial proteins ANT1, the complex II 75 kDa
subunit, and CyP-D increased during development (Figure S2A),
indicating that E9.5 hearts contained a reduced mitochondrial
population compared to older ages. These observations were
corroborated with imaging experiments, in which myocytes
from different ages were loaded with MTG, and mitochondrial
mass was measured (Figure S1C).
Mitochondrial Function Changes as the Embryonic
Heart Ages
Next, we examined mitochondrial function in cultured myocytes
bymeasuring mitochondrial membrane potential (Dcm) and ROS
levels. To compareDcm between specimens, the ratio was taken
of tetramethylrhodamine methyl ester (TMRE) to MTG intensity,
whose retention in the mitochondria is and is not dependent on
Dcm, respectively (Quintanilla et al., 2008). Dcm increased in
cultured cardiac myocytes as the embryo aged (Figures 2A
and 2C), indicating that mitochondrial function matures in coor-
dination with mitochondrial network maturation and cardiac
organogenesis.
To test ETC function during the embryonic period, Dcm was
measured upon addition of different combinations of ETC inhib-
itors (Figures 2E and 2F). First, oligomycin did not cause a drop in
Dcm at any of the ages, indicating that complex V does not main-
tain the Dcm by the hydrolysis of ATP. In contrast, the complex II
inhibitor, malonate, decreased TMRE fluorescence in E9.5 myo-
cytes more than in E13.5 myocytes, while rotenone decreased
TMRE fluorescence in E13.5 myocytes but had no effect on
E9.5 myocytes. These data suggest that at E9.5, complex II is
the primary entry point of electrons into the ETC, and that by
E13.5 complex I becomes important.
Myocyte ROS levels fell during the embryonic period when as-
sayed using 20-70-dichlorofluorescin diacetate (DCF) (Quintanilla
et al., 2009). ROS levels were high throughout the entire cell in
E9.5 myocytes and decreased in the older ages (Figures 2B
and 2D). MitoTracker Red (MTR) was loaded simultaneously
with DCF and revealed that DCF fluorescence localized to the
mitochondria in the later ages (Figure 2B). DCF fluorescence
did not change in the presence of the metal chelator, diethylene-
triaminepentaacetic acid (DTPA; data not shown), confirming
that the DCF signal is due to changes in ROS levels and not to
changes in free iron levels (Tampo et al., 2003).
Mitochondrial Morphology and Function Changes in
Embryonic Cardiac Myocytes upon Closure of themPTP
The changes in mitochondrial structure and function we
observed suggest that early myocytes could have an open
mPTP, which has been associated with collapse of Dcm,
complex I deficiency, and changes in free radical levels (Brookes
et al., 2004; Crompton, 1999; Fontaine et al., 1998; Gunter and
Sheu, 2009; Halestrap, 2009; Lemasters et al., 2009). Generally,
mPTP opening is thought to be a pathologic condition that initi-
ates apoptosis. However, the apoptotic factors cytochrome c
(cyt c) and apoptosis-inducing factor (AIF) localized within the
mitochondria and were not released into the cytosol in E9.5
myocytes, indicating that pathologic opening of the embryonic
mPTP did not occur in these early myocytes (Figures 1B, 1C,
and 4A, and Figure S3B), which agrees with previous data thatevier Inc.
Figure 1. Mitochondrial Morphology Changes during Cardiac Development
(A) Epifluorescence microscopy of MTG in live cultured ventricular myocytes at ages E9.5 and E13.5.
(B) Fixed myocytes stained for a-actinin in the contractile apparatus and AIF in mitochondria.
(C) Fixed myocytes stained for cyt c in mitochondria.
(D) Measurements of mitochondrial length in cultured WT E9.5, E11.5, and E13.5 myocytes (*p < 0.05 compared to E9.5).
(E) Transmission electron micrographs from WT E9.5 and E13.5 hearts.
(F) A histogram of mitochondrial ultrastructure classes from electron micrographs from ventricular myocytes of WT E9.5, E11.5, and E13.5 hearts. The weighted
classifications were significantly different among the three ages (p < 0.05).
All error bars represent SEM.
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embryonic heart (Poelmann et al., 2000).
The absence of mPTP-initiated apoptosis does not preclude
nonpathologic and/or transient mPTP opening, as has been
suggested in some reports (Hausenloy et al., 2010; Wang
et al., 2008). The mPTP is defined by its inhibition by Cyclo-Developmensporin A (CsA), an immunosuppressant that binds to mitochon-
drial CyP-D to block the calcium ion-induced permeability
transition (Basso et al., 2005; Friberg et al., 1998). Opening of
the mPTP causes the IMM to become permeable and leads
to free movement of ions and dissipation of the Dcm (Baines
and Molkentin, 2009; Brookes et al., 2004; Crompton, 1999;tal Cell 21, 469–478, September 13, 2011 ª2011 Elsevier Inc. 471
Figure 2. Mitochondrial Function Changes as the Embryonic Heart Ages
(A and B) Epifluorescence microscopy of TMRE with MTG (A) and DCF with MTR (B) in cultured myocytes at E9.5 and E13.5.
(C and D) Measurements of Dcm (C, TMRE normalized to MTG) and ROS (D, DCF fluorescence) in cultured E9.5, E11.5, and E13.5 myocytes (*p < 0.05 compared
to E9.5).
(E and F) Representative traces ofDcm inmyocytes treated with 1 mg/ml oligomycin (Oligo), then either 1 mM rotenone (Rot, E) or 2mMmalonate (Mal, F), followed
by 1 mM FCCP. Data are shown as ratio of fluorescence at any time point to first time point.
Bar graphs represent the percent (%) change in TMRE after addition of rotenone or malonate compared to the total change after addition of the protonophore,
FCCP (*p < 0.05 compared to E9.5). All error bars represent SEM.
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2009). To determine if the mPTP was open in E9.5 myocytes,
we used the cobalt/calcein AM quenching method (Petronilli
et al., 1999). In untreated E9.5 myocytes, cobalt quenched
calcein fluorescence throughout the cell and in mitochondria
due to free movement of these molecules through an open
mPTP. However, when cultures of E9.5 myocytes were treated
with 500 nM CsA for 2 hr, mitochondrial calcein fluorescence
increased, indicating that CsA closed the mPTP, preventing
cobalt entry (Figure 3E).
More importantly, treatment with CsA for 2 hr increased mito-
chondrial length and Dcm and decreased ROS levels (Figure 3) in
E9.5 myocytes. In contrast, at E11.5 and E13.5, CsA did not
significantly change mitochondrial length, Dcm, or ROS levels
(Figures S2C–S2E) compared to age-matched wild-type (WT)
controls. In addition to blockingmPTP opening, CsA also inhibits
the phosphatase calcineurin. Therefore, to determine if the calci-
neurin pathway was involved in these changes, we treated cells
with FK-506, which blocks calcineurin activity via its receptor
FKBP12, yet has no effect on the mPTP (Friberg et al., 1998).
Treatment with 500 nM FK-506 for 2 hr had no effects on any
of the parameters tested above at any of the ages (Figures 3
and Figures S2C–S2E), suggesting that the CsA effects were
specific to inhibition of the mPTP.
The mPTP is regulated by CyP-D expression and function
(Baines and Molkentin, 2009; Brookes et al., 2004; Crompton,472 Developmental Cell 21, 469–478, September 13, 2011 ª2011 Els1999; Gunter and Sheu, 2009; Halestrap, 2009; Lemasters
et al., 2009), and CyP-D is expressed in the embryonic heart
(Figure S2A). Thus, we examined myocytes from CyP-D null
mice, in which mPTP is resistant to opening (Baines et al.,
2005; Elrod et al., 2010). Although embryonic and cardiac
morphology of the CyP-D null embryos was generally normal,
we have found a number of E9.5 and E11.5 litters with a wider
range of apparent embryonic age than is usually seen in WT
litters. For example, one recent E11.5 litter contained embryos
ranging from E8.75 to E11.5; two E10.5 embryos were dead,
and the E8.75 embryo contained an abnormal heart with a
bulbous left ventricle and a thin outflow tract (data not shown).
Many mitochondria from E9.5 CyP-D null hearts displayed
almost mature cristae, and quantification showed that the
ultrastructure of E9.5 CyP-D mitochondria was not significantly
different from those in either WT E9.5 or E11.5 myocytes, sug-
gesting that the maturation of these mitochondria lay some-
where in between (Figures 3C and 3D). In addition, cultured
E9.5 CyP-D null myocytes had significantly increased mitochon-
drial length andDcm and lower ROS levels compared toWT E9.5
controls (Figure 3). In contrast, cultured E11.5 and E13.5 CyP-D
null myocytes showed no significant differences in these para-
meters compared to WT controls (Figures S2C–S2E). These
results further suggest that the mPTP is open in WT E9.5 myo-
cytes and that its closure in later ages improves mitochondrial
function in the developing heart.evier Inc.
Figure 3. Mitochondrial Structure and Function Changes after Closure of the mPTP
(A) Epifluorescence microscopy of MTG in live E9.5 cultured ventricular myocytes: WT, WT with 500 nM CsA for 2 hr, and CyP-D null (CyP-D KO) myocytes.
(B) Mitochondrial length in culturedWT E9.5 myocytes with and without treatment with 500 nMCsA or 500 nM FK-506 for 2 hr, CyP-D null E9.5myocytes, andWT
E11.5 and E13.5 myocytes (*p < 0.05 compared to WT E9.5).
(C) Electron micrographs of WT E9.5 and CyP-D null E9.5 hearts.
(D) A histogram of mitochondrial ultrastructure classes in electron micrographs from ventricular myocytes of WT E9.5, E11.5, E13.5, or CyP-D null E9.5 hearts.
(E) Images of E9.5 cultured ventricular myocytes stained with calcein-AM in the presence of CoCl2. Quantification showed increased calcein fluorescence after
treatment with 500 nM CsA (*p < 0.05).
(F and G) Measurements ofDcm (F) and ROS (G) in culturedWT E9.5 myocytes with and without treatment with 500 nMCsA or 500 nM FK-506 for 2 hr, CyP-D null
E9.5 myocytes, and WT E11.5 and E13.5 myocytes (*p < 0.05 compared to WT E9.5).
All error bars represent SEM.
Expanded graphical data are provided in Figures S2C–S2E.
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CsA has been shown to enhance cardiac myocyte differentiation
from embryonic stem cells in a calcineurin and NFAT-indepen-
dent manner (Yan et al., 2009). To determine if the mPTP plays
a role in myocyte differentiation in the embryo, the Z bands of
cultured cardiac myocytes were labeled for the striated muscle
isoform of sarcomeric a-actinin (Borisov et al., 2008). TheDevelopmennumber of myocyte Z bands increased in WT myocytes during
the embryonic period, validating this assay as a measure of
differentiation (Figures 4 and 6, and Figure S2F). Closure of the
mPTP at E9.5, by treating cultures with CsA for 24 hr or exam-
ining CyP-D null myocytes, caused a significant increase in the
number of Z bands compared to E9.5 WT controls (Figure 4).
In contrast, these effects on differentiation were not seen intal Cell 21, 469–478, September 13, 2011 ª2011 Elsevier Inc. 473
Figure 4. Closure of the Embryonic mPTP Enhances Myocyte Differentiation
(A) Cultured WT E9.5 myocytes with and without treatment with 500 nM CsA or 500 nM FK-506 for 2 hr, CyP-D null (KO) E9.5 myocytes, and WT E13.5 myocytes
were stained with antibodies to a-actinin and AIF to label Z bands and mitochondria (mito), respectively.
(B) Quantification of Z band number in WT E9.5 myocytes with and without treatment with 500 nMCsA or 500 nM FK-506 for 2 hr, CyP-D null E9.5 myocytes, and
WT E11.5 and E13.5 myocytes (*p < 0.05 compared to WT E9.5).
All error bars represent SEM.
Expanded graphical data and details of quantification are provided in Figures S2F and S3A.
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mPTP Control of Cardiomyocyte DifferentiationE11.5 and E13.5 myocytes (Figure S2F). As above, the effects of
CsA onmyocyte differentiation were likely not due to its inhibition
of calcineurin, as FK-506 did not alter the number of Z bands
in E9.5 WT myocytes (Figure 4), and treatment of CyP-D null
myocytes with either CsA or FK-506 had no effect (data not
shown).
Electron micrographs of E9.5 and E11.5 WT and CyP-D hearts
demonstrated similar changes in differentiation in vivo (Figure 5).
E9.5 (25–26 somites) WT hearts were only 2–3 cell layers thick
and composed of myocytes and an inner layer of endocardial
cells. The myocytes contain few, relatively immature myofibrils
that spanned the cell generally perpendicular to the long axis
of the heart tube. In contrast, E9.5, somite-matched CyP-D
hearts had more cell layers with evidence of early trabeculation,
and the cells had more myofibrils, which tended to appear more
organized compared to WT cells. As with the in vitro data, by
E11.5 these differences were not apparent. In both WT and
CyP-D null hearts, myocytes in the compact myocardium (the
wall) contained few myofibrils, although more were seen in cells
near the ventricular lumen, while the trabeculae of both geno-
types were more differentiated and contained more myofibrils,
as expected (Porter et al., 2011).
To confirm the importance of mPTP closure and to determine
the effects of its sustained opening, we treated cultures with the474 Developmental Cell 21, 469–478, September 13, 2011 ª2011 ElsANT antagonist, bongkrekic acid (BKA), and agonist, carboxya-
tractyloside (CAT), which close and open the mPTP, respec-
tively. These agents had the expected effects on mPTP activity
in calcein quenching experiments (Figure S2B). Treating WT
E9.5 myocytes with BKA increased the number of Z bands
compared to controls, yet had no effect on E13.5 myocytes
(Figure 6). In contrast, opening of the mPTP with CAT for 24 hr
inhibited Z band formation in E13.5 myocytes but had no effect
on E9.5 myocytes (Figure 6). These data further suggest that
closure of the mPTP after E9.5 may control myocyte
differentiation.
Changes in ROS Levels Lie Downstream of mPTP
Closure to Regulate Myocyte Differentiation
The experiments presented above demonstrated that closure of
the mPTP is associated with (Figures 2B and 2D) or may lead to
(Figure 3G) a decrease in ROS levels in embryonic myocytes.
Alternatively, ROS are known to stimulate mPTP opening. There-
fore, we tested whether the mPTP lies upstream of redox
signaling to affect the differentiation of cultured E9.5 myocytes.
Specimens were treated with 6-Hydroxy-2,5,7,8-tetramethyl-
chroman-2-carboxylic acid (Trolox), an anti-oxidant, or tert-butyl
hydroperoxide (tBHP), a stable oxidant, for 24 hr. Trolox alone or
with concurrent CAT treatment enhanced differentiation, whileevier Inc.
Figure 5. CyP-D Deletion Accelerates Myocyte Differentiation of E9.5, but Not E11.5, Myocytes In Vivo
Images (3,5003magnification) taken of the left ventricular wall of E9.5 (25–26 somites) and E11.5 hearts and trabeculae of E11.5 hearts fromWT and CyP-D null
embryos. Arrows indicate examples of Z bands of the myofibrils. En, endothelial cell; L, luminal side of the wall; Ep, epicardial surface.
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tiation (Figure 6). These data suggest that early myocyte differen-
tiation is regulated by changes in ROS levels and that this
mechanism lies downstream of mPTP closure.
DISCUSSION
Several studies have shown the importance of mitochondria and
mPTP activity in cardioprotection and the pathophysiology of
cardiomyopathies (Baines et al., 2005; Burelle et al., 2010).
However, the role of mitochondrial biology in the developing
heart is poorly understood, although a few reports indicate that
mitochondria regulate cardiac stem cell and skeletal myocyte
differentiation (Chung et al., 2007; De Palma et al., 2010; Yan
et al., 2009). Our results not only characterize the development
of mitochondrial structure and function during embryonic
cardiac myocyte differentiation but further demonstrate that
the mPTP lies upstream of changes in mitochondrial mor-
phology, mitochondrial function, and myocyte differentiation.
These results highlight changes in two mechanisms by which
themPTPmay regulate cardiacmyocyte differentiation: bioener-
getics and redox signaling.
First, changes in mPTP activity may affect myocyte bioener-
getics to regulate myocyte differentiation. In the developing
heart, cardiac energetic demands must increase dramatically
to match increasing cardiac performance required by embryonic
growth (Conway et al., 2003; Porter et al., 2011), and closure of
the mPTP may quickly increase ATP production by increasing
the coupling of the ETC and ATP synthase. In addition, Elrod
and colleagues recently demonstrated that mitochondria from
CyP-D null hearts maintain approximately 2-fold higher calcium
content at baseline, resulting in greater mitochondrial activity
and enhanced glucose utilization (Elrod et al., 2010). Similar
control of calcium levels in themitochondrial matrix in the embry-
onic heart may account, in part, for the changes in ETC activity
we observed during embryonic cardiac development and mayDevelopmenresult in increased ATP production. Finally, intrinsic changes in
ETC complex composition and activity, such as we observed
for complex I, may play a role in this process. Therefore, we pro-
pose that as the mPTP closes, mitochondrial function increases,
and an increase in ATP production may allowmyocytes to differ-
entiate to a stage in which they are able to provide the contractile
force needed to ensure adequate circulation and embryonic
survival.
Second, our results suggest that mPTP activity regulates
cellular redox signaling during myocyte differentiation, and
although themechanisms by which mPTP regulates ROS remain
to be determined, we speculate that complex I is involved, as it
is a major source of mitochondrial ROS. We found that E9.5
myocytes were highly oxidized, but closure of the mPTP
decreased ROS levels and enhanced myocyte differentiation.
Antioxidant treatment also enhanced differentiation of E9.5
myocytes, while oxidant treatment significantly inhibited differ-
entiation in both E9.5 and E13.5 myocytes. These data suggest
a link between the mPTP, redox signaling, andmyocyte differen-
tiation, which we tested by combining agents that affected the
mPTP and oxidative state. Upon treatment of E9.5 myocytes
with the antioxidant concurrent with the mPTP-inducing CAT
treatment, myocyte differentiation remained enhanced. In con-
trast, when E9.5 myocytes were treated with oxidant concurrent
with the mPTP-closing BKA treatment, myocyte differentiation
remained inhibited. Together, these observations suggest that
the control of ROS levels could be a mechanism by which the
mPTP regulates differentiation between E9.5 and E11.5. Consis-
tent with this idea are recent studies that show that embryonic
stem cells also rely on redox signaling during differentiation
into cardiac myocytes (Buggisch et al., 2007).
Opening of the mPTP in the Early Embryonic Heart May
Play a Protective Role
According to the data presented in Krishnan et al. (2008),
between E8.5 and E10 the pO2 in the mouse heart is lowertal Cell 21, 469–478, September 13, 2011 ª2011 Elsevier Inc. 475
Figure 6. Myocyte Differentiation Is Regulated by Changes in Oxidative Stress Downstream of mPTP Activity
(A) Cultured WT E9.5 and E13.5 myocytes were treated with 100 mM BKA, 100 mM CAT, 100 mM 6-Hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid
(Trolox), or 10 mM tert-butyl hydroperoxide (tBHP) from 24 to 48 hr in culture and stained with antibodies to a-actinin to label Z bands.
(B) Quantification of Z band number in WT E9.5 and E13.5 myocytes treated with combinations of BKA, CAT, Trolox, or tBHP from 24 to 48 hr in culture (p < 0.05
compared to WT *E9.5 or **E13.5).
All error bars represent SEM.
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in the rest of the embryo at that age due both to a lack of effective
placental circulation and increased energy requirements of the
heart, which has begun to beat and circulate blood. After E10,
the pO2 of the heart is higher due to the initiation of effective
placental circulation. Therefore, major changes occur in the
physiology of the heart between E9.5 and E11.5 as oxygen
supply and energy demands increase.
The purpose of this mPTP-mediated delay of differentiation in
early development may be, in part, to compensate for physiolog-
ical changes that have yet to occur. The increase in energy
demands likely requires dramatic maturation of mitochondrial
function. However, the low oxygen supply at E9.5 may inhibit
this maturation; e.g., these very immature myocytes have few
mitochondria with immature mitochondrial structure and func-
tion as well as high oxidative stress, despite the low oxygen
tension. This paradoxically high oxidative stress may be due to
an immature ETC, decreased antioxidant defenses that are
controlled by mitochondria (Aon et al., 2010), or a yet undeter-
mined mechanism. We hypothesize that the high ROS levels
and low ATP production from immature mitochondria may
prevent further myocyte differentiation in order to protect the
heart during this period of low oxygen supply. Yet, as the
placental circulation is established and oxygen supply increases,
mitochondria mature, leading to decreased oxidative stress and
increased ATP production. This maturation allows myocytes to
differentiate directly via redox signaling and indirectly by
increasing available energy, as discussed above.476 Developmental Cell 21, 469–478, September 13, 2011 ª2011 ElsIf this is the case, then changes in the function of the mPTP
may cause abnormal differentiation of cardiac myocytes and
disrupt cardiac morphogenesis. Although it was initially reported
that CyP-D null mice have no cardiac phenotype and survive
gestation and have a normal life span (Baines et al., 2005; Basso
et al., 2005; Nakagawa et al., 2005), we observed ‘‘premature’’
mitochondrial maturation and myocyte differentiation in E9.5
CyP-D null myocytes compared to WT controls. In contrast we
found that myocytes from older CyP-D null hearts were indistin-
guishable from their WT controls, suggesting a critical period
between E9.5 and E11.5 for mPTP closure that may not neces-
sarily be pathologic. However, the abnormal variation in devel-
opmental stages in occasional litters of CyP-D mice we have
observedmay also indicate subtle pathology in the early embryo.
Moreover, a recent paper shows that CyP-D mice do have
abnormal cardiac physiology, particularly when placed under
stress (Elrod et al., 2010). Therefore, deletion of CyP-D may
not be completely benign.
In contrast, although deletion of CyP-D and closure of the
mPTP, with the resulting mild acceleration of cardiac myocyte
differentiation, are generally tolerated, we postulate that the
converse phenomenon, sustained opening of the mPTP, would
be much more devastating. If this were to occur, then mitochon-
drial maturation and myocyte differentiation would be inhibited
leading to an inability of the developing heart to meet the
demandsof the growing embryo. Future experiments thatmanip-
ulate mPTP opening and closing via changes in CyP-D and other
putative components such as ANT may answer these questions.evier Inc.
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mPTP Control of Cardiomyocyte DifferentiationSummary and Future Directions
In conclusion, these results demonstrate that mPTP function
regulates myocyte differentiation directly via redox-signaling
pathways and suggest that these changes in mPTP function,
mitochondrial maturation, and ROS levels are a mechanism
that protects the embryonic heart during a period of increasing
energy demands but low oxygen supply. Therefore, these data
may have clinical implications by suggesting that some cardio-
myopathies and congenital heart defects may be due to disrup-
tion of myocyte differentiation secondary to defects in mPTP
activity, mitochondrial maturation, and redox biology. Thus, not
only does this research define the important role ofmitochondrial
maturation and redox state in the developing heart, but it also
may lead to therapeutic innovations to promote mPTP closure
or decrease oxidative stress to accelerate myocyte differentia-
tion in cardiac development, cardiomyopathies, and cardiac
regeneration. Finally, these data suggest that increased IMM
permeability is physiologic in the developing heart and that
CyP-D activity is a mechanism by which mPTP is regulated in
the early heart. Future studies should determine themechanisms
that control mPTP activity in the developing myocyte and further
characterize the redox-signaling pathways that lie downstream
of mitochondrial function to control myocyte differentiation in
the developing heart.
EXPERIMENTAL PROCEDURES
Animals
All experiments were performed using WT C57BL/6N mice or CyP-D null mice
in a C57BL/6 background. Embryos were harvested at E9.5, E11.5, and E13.5
based on timed matings and on the morphology of the embryo.
Fluorescent Imaging and Analyses
Embryonic ventricles and outflow tracts were dissociated with papain and
cultured in Dulbecco’s modified Eagle’s medium with fetal bovine serum
and antibiotics (Polo-Parada et al., 2009). Live cultures were labeled with
TMRE (20 nM), DCF (1 mM), MTG or MTR (200 nM), or calcein AM (1 mM)
with cobalt chloride (1 mM). Fixed cultures were permeabilized and labeled
with antibodies to AIF, cyt c, or a-actinin and fluorescent secondary anti-
bodies. Images were taken using confocal and epifluorescence microscopes
and analyzed using ImageJ or Image Pro 6 software.
Determination of Mitochondrial Structure and Function
Analysis of mitochondrial length, aspect ratio (AR), form factor (FF), and area
were quantified in live cells labeled with MTG (Hom et al., 2007; Quintanilla
et al., 2009). Dcm was quantified as the ratio of TMRE to MTG intensity. Live
cultures were loaded for 35 min with TMRE and MTG in HEPES-Tyrode’s
buffer, washed, and equilibrated for 20 min in the same buffer. ROS levels
were measured by incubating cultures with DCF and MTR for 30 min in
Krebs-Ringer-HEPES buffer supplemented with 5 mM glucose at 37C,
washed, and examined in the same buffer. ROS levels were expressed
as average of fluorescence signal (F) minus background fluorescence (F0)
(Quintanilla et al., 2009).
Determination of Myocyte Differentiation
Cultured myocytes were labeled with an anti-sarcomeric a-actinin antibody
and analyzed as in Figure S3A to count the number of Z bands per cell.
EM
Pregnant dams were sacrificed by cervical dislocation, and uterine segments
were rapidly removed and dissected in EM fixative. Specimens were postfixed
in 1% osmium tetroxide and embedded in EPON/Araldite resin. Seventy nano-
meter sections were stained with aqueous uranyl acetate and lead citrate.
Sections were examined and photographed using a Hitachi 7650 TEM.DevelopmenWestern Blot Analysis
Homogenates of embryonic ventricles and outflow tracts were run on an SDS-
polyacrylamide gel, transferred to nitrocellulose membranes, and probed with
mouse anti-ANT1, CyP-D, and 75 kDa subunit of complex II.
Statistics
Statistical analyses were conducted using Prism or SAS System for Windows.
Fluorescence data were analyzed using t tests, ANOVA followed by Dunnett’s
post-hoc testing, or Kruskal-Wallis test with Dunn’s post-hoc testing. Mito-
chondrial ultrastructural classes were analyzed using a random effects model
followed by pairwise comparisons using Tukey-Kramer adjustment. In all
cases, a p value for significance was set at 0.05. All error bars represent
SEM unless otherwise noted.
For details of Experimental Procedures, please see the Supplemental
Information.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and three figures and can be found with this article online at doi:10.1016/
j.devcel.2011.08.008.
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